Peer Reviewed Journals

Breen EG, Cormican M, Connolly CE, Stevens FM, McCarthy CF. (1989) 'Ulcerative Enteritis: Atypical features'. Irish J. Med Sci, 158 :105-106. [Details]

Cormican M, Nyman C. (1990) 'Intrapericardial bleomycin for the management of cardiac tamponade secondary to malignant pericardial effusion'. Brit. Heart J, 63 :61-62. [Details]

Cormican M, Lowe D, Keane P, Flynn J, O'Toole D. (1991) 'The microbial flora of use in blood pressure cuffs'. Irish J. Med. Sci, 160 :112-113. [Details]

Cormican MG, El Bouri K, Corbett-Feeney G, Flynn J. (1992) 'Staphylococcus lugdunensis endocarditis'. Journal of Infection, 25 :335-336. [Details]

Cormican M, Barry T, Gannon F, Flynn J. (1992) 'Use of polymerase chain reaction for early identification of Mycobacterium tuberculosis in positive cultures'. J. Clin. Path, 45 :601-604. [Details]

Cormican M, Flynn J. (1992) 'Tuberculosis in the West of Ireland 1986-1990'. Irish J. Med. Sci, 161 :70-72. [Details]

CORMICAN, MG,BARRY, T,GANNON, F,FLYNN, J (1992) 'USE OF POLYMERASE CHAIN-REACTION FOR EARLY IDENTIFICATION OF MYCOBACTERIUM-TUBERCULOSIS IN POSITIVE CULTURES'. Journal Of Clinical Pathology, 45 :601-604. [Details]

Cormican MG, Collins T. (1993) 'Mycobacteria and human disease. (Review)'. Journal of Biomedical Sciences, 3 :64-71. [Details]

Hannan M, Cormican M, Flynn J. (1993) 'A Comparison of antimicrobial sensitivities of urinary pathogens for the years 1980 and 1990'. Irish J. Med. Sci, 162 :499-501. [Details]

CORMICAN, M,GLENNON, M,RIAIN, UN,FLYNN, J (1995) 'MULTIPLEX PCR FOR IDENTIFYING MYCOBACTERIAL ISOLATES'. Journal Of Clinical Pathology, 48 :203-205. [Details]

Cormican MG, Pfaller MA. (1996) 'Molecular pathology of infectious diseases'. In: Henry JB. Clinical Diagnosis and Management by Laboratory Methods 19th Edition, . [Details]

Cormican MG, Marshall SA, Jones R.N. (1996) 'Detection of extended-spectrum beta-lactamase (ESBL)-producing strains by the Etest ESBL screen'. J.Clin.Microbiol, 34 :1880-1884. [Details]

Jones RN, Cormican MG, Wanger A. (1996) 'Clindamycin resistance among erythromycin-resistant streptococcus pneumoniae'. Diagn Microbiol Infect.Dis, 25 :210-204. [Details]

Cormican MG, Jones RN. (1997) 'Antimicrobial Activity and Spectrum of LB20304, A novel fluoronaphthyridone. Antimicrob Agents'. Chemother, 41 :204-211. [Details]

Cormican M, Pfaller MA. (1997) 'Microbiology: The role of the clinical laboratory'. In: Wenzel RP. Prevention and Control of Nosocomial Infections, . [Details]

Cormican, M,Morris, D,Corbett-Feeeney, G,Flynn, J (1998) 'Extended spectrum beta-lactamase production and fluorquinolone resistance in pathogens associated with community acquired urinary tract infection'. Diagnostic Microbiology And Infectious Disease, 32 :317-319. [Details]

Cormican M, Morris D, Corbett-Feeney G, Flynn J. (1998) 'Extended spectrum beta-lactamase production and fluoroquinolone resistance in pathogens associated with community acquired urinary tract infection'. Diagnostic Microbiology and Infectious Disease, 32 :317-319. [Details]

Maher M, Glennon M, Cormican M. (1998) 'Application of PCR to the detection of M. tuberculosis in sputum samples'. In: Lo Y.M.D. Methods in Molecular Medicine. Humana Press Inc., Totowa, NJ. 1998, 16 . [Details]

Cormican, M,Corbett-Feeney, G,Kelly, S,Hughes, D,Flynn, J,Jones, RN (1998) 'In-vitro activity of piperacillin/tazobactam relative to other antibiotics against blood culture isolates'. Irish Journal Of Medical Science, 167 :155-159. [Details]

Kelly B, Finnegan P, Cormican M, Callaghan J. (1999) 'Lyme disease and glomerulonephritis'. Irish Medical Journal, 92 :372-372. [Details]

Richter S, Cormican MG, Pfaller MA, Lee CK, Gingrich R, Rinaldi MG, Sutton DA. (1999) 'Fatal disseminated Trichoderma longibrachiatum infection in an adult bone marrow transplant patient'. Journal of Clinical Microbiology, 37 :1154-1160. [Details]

Kelly S, Cormican MG, Parke L, Corbett-Feeney G, Flynn J. (1999) 'Cost effective methods for isolation of Salmonella enterica in a clinical laboratory'. Journal of Clinical Microbiology, 37 :3369-3369. [Details]

Daly M, Buckley J, Power E, O'Hare C, Cormican M, Cryan B, Wall PG, Fanning S. (2000) 'Molecular characterization of Irish Salmonela enterica Serotype Typhimurium and assessment of genetic relationships by DNA amplification'. Applied and Environmental Microbiology, 66 :614-619. [Details]

Cormican M, Collignon P, van den Bogaard, T. (2000) 'The DDT Question'. Lancet, 356 . [Details]

Whyte T, Hanahoe B, Collins T, Corbett-Feeney G, Cormican M. (2000) 'Evaluation of the Bactec MGIT 960 and MB BAC/T systems for routine detection of Mycobacterium tuberculosis'. J. Clinical Microbiology, 38 :3131-3132. [Details]

Whyte, T. Hanahoe B, Collins T, G. Corbett-Feeney G, Cormican M. (2000) 'Evaluation of the BACTEC MGIT 960 and MB BAC/T systems for routine detection of Mycobacterium tuberculosis'. Journal of Clinical Microbiology, 38 . [Details]

O'Connor, D, Hynes P, Cormican M, Collins E, Corbett-Feeney G and Cassidy M. (2001) 'An evaluation of methods for toxin detection in specimens of faeces submitted for diagnosis of Clostridium difficile-associated diarrhoea'. Journal of Clinical Microbiology, 39 (8):2846-2849. [Details]

Foley B, Cormican M, Fitzgerald M, McKeown P. (2001) 'Epidemiology of Salmonella infection in Ireland, 2000'. Epi-Insignt, 2 (9). [Details]

Glennon M, Cormican M. (2001) 'Detection and diagnosis of mycobacterial pathogens using PCR'. Expert Reviews in Molecular Diagnostics, 1 :163-174. [Details]

Cormican M. (2001) 'Evaluation of a PCR/DNA Probe Colorimetric Membrane Assay for Identification of Campylobacter spp. in Human Stool Specimens'. J Clin Microbiol, 39 (11):4163-4165. [Details]

Cormican MG, Pfaller MA. (2001) 'Molecular pathology of infectious diseases'. In: Henry JB. Clinical Diagnosis and Management by Laboratory Methods 20th Edition. WB Saunders. Philadelphia. 2001. 1241-1253, . [Details]

Cormican M, Buckley V, Corbett-Feeney G, Sheridan M. (2001) 'Antibiotic resistance in E. coli isolates from turkeys and hens in Ireland'. Journal of Antimicrobial Chemotherapy. J Antimicrob Chemother, 48 (4):587-588. [Details]

Cormican M, DeLappe N, O'Hare C, Doran G, Morris D, Corbett-Feeney G, Séamus Fanning S, Daly M. (2002) 'Salmonella enterica serotype Bredeney, antimicrobial susceptibility and molecular diversity of isolates from Ireland and Northern Ireland'. Applied and Environmental Microbiology, 68 :181-186. [Details]

Maher M, Finnegan C, Collins E, Ward B, Carroll C, Cormican M. (2003) 'Evaluation of culture methods and a DNA probe-based assay for detection of Campylobacter species in clinical specimens of faeces'. J Clin Microbiol, 41 :2980-2986. [DOI] [Details]

Curtin J, Cormican M, Fleming G, Keelehan J, Colleran E. (2003) 'Linezolid compared with eperezolid, vancomycin and gentamicin in an in vitro model of antimicrobial lock therapy for Staphylococcus epidermidis central venous catheter-related biofilm infections'. Antibicrob. Agents Chemother, 47 (10):3145-3148. [DOI] [Details]

Moore JE, Murray L, Fanning S, Cormican M, Daly M, Delappe N, Morgan B, Murphy PG. (2003) 'Comparison of phenotypic and genotypic characteristics of Salmonella bredeney associated with a poultry-related outbreak of gastroenteritis in Northern Ireland'. Journal of Infection, 47 :33-39. [DOI] [Details]

Threlfall EJ, Fisher IS, Berghold C, Gerner-Schmidt P, Tschape H, Cormican M, Luzzi I, Schneider F, Wannet W, Machado J, Edwards G. (2003) 'Antimicrobial drug resistance in isolates of Salmonella enterica from cases of salmonellosis in humans in Europe in 2000: results of an international multicentre surveillance'. Euro Surv, 8 :41-45. [DOI] [Details]

Gray S, Glancy J, O' Hare C, Doran, G, Cormican M. (2003) 'Failure to detect Salmonela enterica serovar Dublin on Aes Laboratiore Salmonella agar plate'. J. Clin. Microbiol, 41 (8). [Details]

Delappe N, O' Halloran F, Fanning S, Corbett-Feeney G, Cheasty T, Cormican M. (2003) 'Antimicrobial resistance and genetic diversity of Shigella sonnei isolates from Western Ireland, an area of low incidence of infection'. J. Clin. Microbiol, 41 :1919-1924. [Details]

Morris D, O' Hare, C, Glennon, M, Maher M, Corbett-Feeney, G, Cormican M. (2003) 'Extended-spectrum beta-lactamases in Ireland, including a novel enzyme, TEM-102'. Antimicrob. Agents. Chemother, 47 :2572-2578. [DOI] [Details]

Joyce M, Laing A, Mullet H, Gilmore MF, Cormican M. (2003) 'Isolated septic arthritis: meningococcal infection'. J R Soc Med, 96 :237-238. [Details]

Threlfall EJ, Fisher IS, Berghold C, Gerner-Smidt P, Tschape H, Cormican M, Luzzi I, Schneider F, Wannet W, Machado J, Edwards G. (2003) 'Trends in antimicrobial resistance in Salmonella enterica serotypes Typhi and Paratyphi A isolated in Europe 1999-2001'. Int. J. Antimicrob. Agents, 22 (5):487-491. [DOI] [Details]

Gorman J, Cormican M. (2004) 'Panton-Valentine leukocidin producing strains associated with serious community acquired S. aureus infection in Ireland'. Eurosurveillance Weekly Archives, 8 (44). [Details]

Curtin J, Cormican M. (2004) 'Measuring antimicrobial activity against biofilm bacteria'. In: Abstracts of the Re/Views in Environmental Science and Bio/Technology, 1-7, 2004 Klumer Academic Publishers.Netherlands (July 2004), . [Details]

Cormican M. (2004) 'The essential role of the national salmonella reference laboratory in fighting human salmonellosis'. FSAI News (Food safety of Ireland), . [Details]

NiChulain M, Murray AM, Corbett-Feeney G, Cormican M. (2005) 'Antimicrobial resistance in E. coli associated with urinary tract infection in the west of Ireland'. Ir J Med Sci, 174 :6-9. [DOI] [Details]

Kilmartin D, Morris D, O'Hare C, Corbett-Feeney G, Cormican M. (2005) 'Clonal expansion may account for high levels of quinolone resistance in Salmonella enterica serovar enteritidis'. Appl Environ Microbiol, 71 :2587-2591. [DOI] [Details]

Coia J, Cormican M, Ethelberg S, Fisher I. (2005) 'Outbreak of Salmonella Goldcoast affecting tourists exposed in Majorca from UK, Ireland, Sweden, Norway and Denmark'. Eurosurveillance Weekly, 10 ((10) 27):4-5. [Details]

Doran G, Morris D, O'Hare C, DeLappe N, Bradshaw B, Corbett-Feeney G, Cormican M. (2005) 'Cost -effective application of Pulsed-Field Gel Electrophoresis to typing Salmonella enterica serovar Typhimurium'. App. Environ. Micro, 71 :8236-8240. [DOI] [Details]

Cormican, M, Morris, D.Doran G, Morris D, O'Hare C, DeLappe N, Bradshaw B, Corbett-Feeney G, (2005) 'Ask an expert “Drugs versus Superbugs: the problem with antibiotic resistance”'. Relay E-newsletter, (5). [Details]

Doran G, Sheridan F, DeLappe N, O'Hare D, Anderson W, Corbett-Feeney G,Cormican M. (2005) 'Salmonella enterica serovar Kedougou contamination of commercially grown mushrooms'. Diagnostic Microbiology and Infectious Disease, 51 :3-76. [Details]

O'Connor L, Lahiff S, Casey F, Glennon M, Cormican M, Maher M. (2005) 'Quantification of ALS1 gene expression in Candida albicans biofilms by RT-PCR using hybridization probes on the LightCycler'. Mol Cell Probes, 19 :153-162. [DOI] [Details]

De Souza V, MacFarlane A, Murphy AW, Hanahoe B, Barber A, Cormican M. (2006) 'A qualitative study of factors influencing antimicrobial prescribing by non-consultant hospital doctors'. Antimicrob Chemother. 2006 Oct; 58(4):840-3, 58 (4):840-843. [DOI] [Details]

Altaie R, Fahy GT, M. Cormican (2006) 'Failure of Listeria monocytogenes keratitis to respond to topical ofloxacin'. Cornea, 25 (7):849-850. [Details]

McNicholas S, Barber A, Corbett-Feeney G, Cormican M. (2006) 'Linezolid audit: similarities and contrasts with published experience'. J Antimicrob Chemother, 57 :1008-1009. [Details]

DeLappe N, Doran G, Connor JO, Mammina C, Cormican M. (2006) 'Use of pulsed-field gel electrophoresis for comparison of similar but distinguishable isolates of Shigella sonnei collected in Ireland and Italy'. J Clin Microbiol, 44 (10):3808-3810. [DOI] [Details]

Cormican M, Cunningham C, Faherty C, Murphy AW. (2006) 'Importance of clinical features in Diagnosis of Mumps during a Community Outbreak'. Irish Medical Journal, 99 :171-173. [DOI] [Details]

Morris D, Whelan M, Hawkey P, Xu L, Doran G, Corbett-Feeney G, Cormican M. (2006) 'First report of extended spectrum ?-lactamase producing Salmonella in Ireland'. Antimicrob. Agents Chemother, 50 (4):1608-1609. [Details]

Pelly H, Morris D, O'Connell E, Hanahoe B, Chambers C, Biernacka K, Gray S, Cormican M. (2006) 'Outbreak of extended spectrum beta-lactamase producing E. coli in a nursing home in Ireland'. May 2006. Euro Surveill, 11 (8). [Details]

Doran G, NiChulain M, DeLappe N, O'Hare C, Corbett-Feeney G, Cormican M. (2006) 'Interpreting streptomycin susceptibility test results for Salmonella enterica serovar Typhimurium'. Int. J. Antimicrob. Agents, 27 (6). [DOI] [Details]

Pelly H, Cormican M, O'Donovan D, Chalmers RM, Hanahoe B, Cloughley R, McKeown P, Corbett-Feeney G. (2007) 'A large outbreak of cryptosporidisois in western Ireland linked to a public water supply; a preliminary report'. Euorsurveillance, 3 (12). [DOI] [Details]

Mulqueen J, Cafferty F, Cormican M, Keane JD, Rossney A. (2007) 'Nasal carriage of meticillin-resistant Staphylococcus aureus in GPs in the West of Ireland'. Br J Gen Pract, 57 :811-813. [DOI] [Details]

Collins C, Drew R, Cormican M. (2007) 'Ethical considerations regarding the administration of oseltamivir for infection control indications'. Clinical Infect Dis, 45 :133-134. [Details]

Morris D, NiChulain M, Cormican M. (2007) 'Dissemination of Clonal Groups of Uropathogenic E. coli is not a significant contributor to Trimethoprim and Sulfamethoxazole Resistance in Galway, Ireland'. International J. Antimicrob Agents, 30 (1):97-98. [DOI] [Details]

Coffey, R; Cummins, E; Cormican, M; Flaherty, VO; Kelly, S (2007) 'Microbial Exposure Assessment of Waterborne Pathogens'. Human And Ecological Risk Assessment, 13 (6):1313-1351. [DOI] [Details]

Drew R, Cormican M, Fleming C. (2007) 'Low Rate of Co-infection in Patients Presenting with Chlamydia trachomatis to a STI clinic in Galway Ireland'. International Journal of STD and AIDS, 18 . [DOI] [Details]

Cormican M, Hanahoe B, Murphy A. (2007) 'Antimicrobial resistance in the community'. Forum, . [Details]

Morris D, Boyle F, Buckley V, Xu L, Hanahoe B, Hawkey P, Cormican M. (2008) 'CTX-M enzymes are the predominant extended-spectrum beta lactamase produced by Enterobacteriaceae in Ireland'. J. Antimicrob Chemother, 64 :864-866. [DOI] [Details]

Stirling J, Griffith M, Blair I, Cormican M, Dooley J, Goldsmith C, Gloven S, Loughrey A, Lowery C, Matsuda M, McClurg R, McCorry K, McDowell D, McMahon A. (2008) 'Prevalence of Gastrointestinal Bacterial Pathogens in a population of Zoo animals'. Zoonoses Public Health, 55 (3):166-172. [DOI] [Details]

McNicholas S, Hanahoe B, Higgins F, McAnena O, Corbett-Feeney G, Cormican M. (2008) 'Linezolid Resistant Enterococcus faecium: First Reported Isolate'. Irish Medical Journal, 101 (225). [DOI] [Details]

Meakins S, Fisher IS, Berghold C, Gerner-Smidt P. M. Cormican et al. (2008) 'Antimicrobial drug resistance in human nontyphpidal Salmonella islolates in Europe 2000-2004: report from the Enter-net International Surveillance Network'. Microb. Drug Resist, 14 (1):31-35. [DOI] [Details]

O'Flanagan D, Cormican M, McKeown P, Nicolay N, Cowden J, Mason B. Morgan D, Lane C, Irvine N, Browning L. (2008) 'A multi-country outbreak of Salmonella Agona'. Euro-surveillance, 13 (33). [DOI] [Details]

Garvey P, McKeown P, HPSC, DeLappe N, Doran G, O'Connor J, Cormican M, Clancy D, Shanaghy N (2008) 'NSRL;,WRH'. Human listeriosis: surveillance, epidemiology,transmission and prevention EPI-insight, ( ). [Details]

Fennell JP, O'Donohoe M, Cormican M, Lynch M. (2008) 'Linezolid lock prophylaxis of central venous catheter infection'. J. Med Microbiol, 57 :534-535. [DOI] [Details]

Prendergast DM, Duggan SJ, Fanning S, Cormican M, Gonzales-Barron U, Butler F, Duffy G. (2008) 'Prevalence and numbers of Salmonella spp. and Enterobacteriaceae on pork cuts in abattoirs in the Republic of Ireland'. J. Appl. Microbiol, 105 (4):1209-1219. [DOI] [Details]

Hendriksen RS, Mikoleit M, Kornschober C, Rickert RL, Duyne S, Kjelsot, Hasman H.Cormican M, Mevius D, Thnelfall J,Angulo FJ, Aurestnup FM, (2009) 'Emergence of a multidrug resistant Salmonella concord infections in Europe and the United States in children adopted from Ethiopia 2003-2007'. Paed Infect Dis J, 28 :814-818. [DOI] [Details]

DeLappe N, Doran G, O'Connor J, O'Hare C, Cormican M. (2009) 'Characterization of bacteriophages used in the Salmonella enterica serovar Enteritidis phage-typing scheme'. Journal of Medical Microbiology, 58 :86-93. [DOI] [Details]

Farrell H, Garvey M. Cormican M, Laffey J, Rowan N. (2009) 'Investigation of critical inter-related factors the efficacy of pulsed light for inactivating clinically relevant bacterial pathogens'. Journal of Applied Microbiology - 2009- 0389, . [DOI] [Details]

Prendergast DM, Duggan SJ, Fanning S, Cormican M, Gonzales-Barron U, Butler F, Duffy G, (2009) 'Prevalence, numbers and characteristics of Salmonella spp. on Irish retail pork'. Int. J Food Microbial, 131 ((2-3)):233-239. [DOI] [Details]

Kingsley R, Msefula C, Thomson N, Kariuki S, Holt K, Gordon M, Harris D, Clarke L, Whitehead S, Sangal V, Marsh K, Achtman M, Molyneux M, Cormican M, Parkhill J, Macleannan C, Heyderman R, Dougan G. (2009) 'Epidemic multiple drug resistant Salmonella Typhimurium causing invasive disease in Sub-Saharan Africa have a distinct genotype'. Genome Res, 19 :2279-2287. [DOI] [Details]

Callaghan MB, Cormican M, Prendergast M, Pelly H, Hanahoe B, Cloughley R, and O'Donovan D. (2009) 'Temporal and spatial distribution of human cryptosporidiosis in the west of Ireland 2004-2007'. Journal: International Journal of Health Geographics, 8 . [DOI] [Details]

Cummins E, Kennedy R, Cormican M. (2009) 'Quantitative risk assessment of cryptosporidium in tap water in Ireland'. Science of the Total Environment November, . [DOI] [Details]

O'Connell K, Fennell J, Callaghan J, Rowaiye B, Cormican M. (2009) 'A fatal case of Pasteurella multocida epiglottitis'. Ir J Med Sci, 178 (4):541-542. [DOI] [Details]

Cormican M, O'Connell K, Smyth B, Hanahoe B. (2009) 'Prevalence of antenatal Hepatitis B virus carriage in the west of Ireland'. In Press IMJ (Awaiting date of publication), . [Details]

O'Connell E, Martin W, Cormican M, Glacken M, O'Donovan D, Vellinga A, Cahill N, Lysaght F, O'Donnell J. (2009) 'Chlamydia trachomatis infection and sexual behaviour among female students attending higher education in the Republic of Ireland'. BMC Public Health, 9 (397). [DOI] [Details]

DeLappe N, O'Connor J, Doran G, Devane G, Cormican M. (2009) 'Role of subtyping in detecting Salmonella cross contamination in the laboratory'. BMC Microbiology, 9 . [Details]

Boyle F, Morris D, O'Connor J, DeLappe N, Ward J, Cormican M. (2010) 'First report of extended-spectrum-beta-lactamase producing Salmonella Enterica Serovar Kentucky isolated from poultry in Ireland'. Antimicrob Agents Chemother, 54 :551-553. [DOI] [Details]

Vaughan D, O'Connell E, Cormican M, Brugha R, Faherty C, Balfe M, O'Donovan D.   (2010) 'Pee-in-a-Pot: acceptability and uptake of on-site chlamydia screening in a student population in the Republic of Ireland'. BMC Infect Dis, 10 (325). [Details]

Vellinga A 1,2*, Cormican M2,3, Hanahoe B2, Bennett K4, Murphy AW1 (2011) 'Opt-out as an acceptable method of obtaining consent in medical research: a short report'. BMC Medical Research Methodology, 11 (40). [ARAN Link] [Details]

O' Connell K, Boo TW, Keady D, NiRiain U, O' Donovan D, Commane M, Faherty C, Cormican M. (2011) 'Use of palivizumab and infection control measures to control an outbreak of respiratory syncytial virus in a neonatal intensive care unit confirmed by real-time polymerase chain reaction'. J Hosp Infect, 77 (4):338-342. [DOI] [Details]

Vaughan, D., O'Connell, E., Cormican, M., Brugha, R., Faherty, C., Balfe, M., et al. (2020) 'Pee-in-a-Pot: acceptability and uptake of on-site chlamydia screening in a student population in the Republic of Ireland'. BMC Infectious Diseases, 10 (1). [ARAN Link] [Details]

Cormican MG, Johnson DM, Jones RN. 'Activity of the quinupristin/dalfopristin combination (RP-59500, Synercid) tested against vancomycin-resistant enterococcus species'. Diagn. Microbiol. Infect. Dis, 24 :59-60. [Details]

Maher M, Dowdall D, Glennon M, Walshe S, Cormican M, Weisner P, Gannon F, Smith T. 'The sensitive detection of fluorescently labelled PCR products using an automated detection system'. Molecul Cellul Probes, 9 :265-276. [Details]

Scallan E, Fitzgerald M, Cormican M, Smyth B, Devine M, Daly L, Reilly P, Crowley D, O'Sullivan M, Collins C, Harkins V, McKeown P, Tohani V. 'The investigation of acute gastroenteritis in general practice: A survey of general practitioners in Northern Ireland and Republic of Ireland'. European Journal of General Practice, 11 . [Details]

O'Hare C, Doran G, DeLappe N, Morris D, Buckley V, Corbett-Feeney G, Cormican M. 'Antimicrobial resistance and phage types of human and non-human Salmonella enterica isolates in Ireland, 1998-2003'. Commun Dis Public Health, 7 (3):193-199. [Details]

Cormican MG, Erwin ME, Marshall SA, Jones RN. 'Susceptibility testing interpretitive criteria for levofloxacin when testing respiratory pathogens, Haemophilus influenzae and Moraxella catarrhalis'. Diagn. Microbiol. Infect.Dis, 24 :155-160. [Details]

Cormican MG, Jones RN. 'Enterococcus'. In: Schlossberg D. Current Therapy of Infectious Disease. Mosby. Philadelphia, PA.. pp 412-414. This chapter will also appear with modification in Current Therapy in Internal Medicine at the request of the editor, . [Details]

Cormican, MG Jones RN. 'Antimicrobial Resistance's Emerging in Gram-Positive Bacteria (Enterococci, Staphylococci, and Non-Pneumococcal Streptococci)'. Drugs, 51 (1):6-12. [Details]

Cormican MG, Marshall, SA, Jones RN. 'Preliminary interpretive criteria for disk diffusion susceptibility testing of everninomicin'. Diagn. Microbiol Infect. Dis, 23 :157-160. [Details]

Cormican M, Corbett-Feeney G, Kelly S, Hughes D, Flynn J. 'In-vitro activity of piperacillin/tazobactam relative to other antibiotics against blood culture isolates'. Irish Journal of Medical Science, 167 :155-159. [Details]

Pfaller MA, Cormican MG. 'Molecular biology in monitoring resistance'. New Horizons, 4 :361-369. [Details]

Cormican MG, Biedenbach D, Jones RN. 'Evaluation of laboratory methods for detection of antimicrobial resistance among enterococci'. Clin. Microbiol. Infect, 1 :190-194. [Details]

Cormican MG, Jones RN 'Spectrum of antimicrobial activity of and clinical efficacy of ceftibuten in children. Rev. Contemp. Pharmacother. 7:141-147'. . [Details]

Garvey J, Joyce MR, Khan F, Ammar A, Connolly CE, Cormican M, McAnena O. 'Axillary Lymphadenopathy secondary to cat-scratch disease'. . [Details]

Cormican MG, Jones RN. 'The role of teichoplanin in contemporary therapy of enterococcal infection'. Journal of Chemotherapy (Review), 5 :174-179. [Details]

Murphy S, Cormican M, Jones RN. 'Comparative antimicrobial activity and spectrum of activity of CP-99,219, a novel fluoroquinolones, tested against ciprofloxacin-resistant clinical isolates'. Irish Journal of Medical Science, 164 :271-273. [Details]

Cormican MG, Johnson DM, and Jones RN. 'Evaluation of NCCLS and Published Interpretive Criteria for Fluoroquinolone Disk Diffusion Susceptibility Tests as a Guide to Therapy with Marketed and Investigational Compounds'. Clin. Infect. Dis, 21 (748). [Details]

Cormican M, Jones RN. 'Evaluation of in vitro activity of furopenem (SY5555 or SUN5555) against respiratory tract pathogens and beta-lactamase producing bacteria'. J. Antimicrob. Chemother, 35 :535-539. [Details]

Cormican M, Runyon BA, Jones RN. 'In vitro activity of levofloxacin and FK-037 against aerobic isolates from spontaneous bacterial peritonitis'. J. Chemother, 7 :197-200. [Details]

Cormican MG, Erwin ME, Jones RN. 'Bactericidal activity of cefotaxime, desacetylcefotaxime, rifampin, and various combinations tested at cerebrospinal fluid levels against penicillin-resistant Streptococcus pneumoniae'. Diagn. Microbiol. Infect. Dis, 22 :119-124. [Details]

Cormican MG, Jones RN 'Use of a multiplex PCR to detect and identify Mycobacterium avium and M. intracellulare in blood culture fluid of AIDS patients'. J Clin Microbiol, 33 . [Details]

Cormican MG, Jones RN. 'Antimicrobial activity of cefotaxime tested against infrequently isolated pathogenic species (unusual pathogens). (Review)'. Diagn. Microbiol. Infect. Dis, 22 :43-48. [Details]

Cormican MG, Jones RN. 'Re-evaluations of disk diffusion susceptibility testing interpretive criteria for lomefloxacin and norfloxacin using fluoroquinolone-resistant isolates'. Diagn. Microbiol. Infect. Dis, 21 :227-230. [Details]

Cormican M, Marshall S, Jones RN. 'Cross resistance analysis for DU-6859a, a new fluoroquinolone, compared to six structurally similar compounds (ciprofloxacin, clinafloxacin, fleroxacin, levofloxacin, ofloxacin, sparfloxacin)'. Diagn. Microbiol. Infect. Dis, 21 :51-54. [Details]

Cormican M, Jones RN. 'Susceptibility to levofloxacin predicted from in vitro susceptibility testing results obtained with ciprofloxacin and with ofloxacin'. J. Clin. Microbiol, 33 :215-216. [Details]

Cormican M, Glennon M, NiRiain U, Flynn J. . Irish J. Med. Sci, 164 :20-23. [Details]

Cormican MG, Biedenbach DJ, Jones RN. 'Accurate Antimicrobial Susceptibility Testing Methods (Vitek, Etest, Reference MICs) for Enterococci: Vancomycin-Resistance Amongst Clinical Isolates of Enterococcus Species is an Increasing Clinical Problem'. . [Details]

Cormican MG, Pfaller, MA. 'Epidemiology of candidiasis'. Comprehen Ther (Review), 25 :201-204. [Details]

Cormican M, Jones RN. 'In vitro activity of trovafloxacin (CP99,219) tested by two methods against 150 vancomycin-resistant enterococcal isolates'. J Antimicrob Chemother, 37 :847-849. [Details]

Glennon M, Cormican M, NiRiain U, Heginbothom M, Gannon F, Smith T. 'Mycobacterium malmoense specific DNA probe from the 16S/23S rRNA spacer'. Molecul Cellular Probes, 10 :337-345. [Details]

Cormican M, Erwin ME, Jones RN. 'False resistance to metronidazole by E-test among anaerobic bacteria, investigations of contributing test conditions and medium quality'. Diagn Microbiol. Infect.Dis, 24 :117-119. [Details]

Cormican MG, Hollis RJ, Pfaller MA. 'DNA macrorestriction profiles and antifungal susceptibility of Candida (Torulopsis)glabrata'. Diagn.Microbiol. Infect.Dis, 25 :83-88. [Details]

Cormican MG, Pfaller MA. 'Standardisation of antifungal susceptibility testing (Review)'. J. Antimicrob. Chemother, 38 :561-578. [Details]

Cloughley R, Kelehan J, Corbett-Feeney G, Murray M, Callaghan J, Regan P,Cormican M. 'Brain Heart Infusion Broth for isolation of Absidia corymbifera from tissue'. Journal of Clinical Microbiology. In-Press, . [Details]

Morris D, NiChulain M, Cormican M. 'Dissemination of Clonal Groups of Uropathogenic E. coli is not a significant contributor to Trimethoprim and Sulfamethoxazole Resistance in Galway, Ireland'. International J. Antimicrob. Agents, 30 (1):97-98. [Details]

Ni Riain U, Cormican M, Flynn J. 'Transport of digested decontaminated sputum specimens to a central laboratory for testing for M.tuberculosis by Amplicor MTB test'. Irish Journal of Medical Science, 167 :79-80. [Details]

Cormican M, Butler C, Morris D, Corbett-Feeney G, Flynn J. 'Antibiotic Resistance in Salmonella enterica From the Republic of Ireland'. Journal of Antimicrobial Chemotherapy, 42 :116-118. [Details]

Jones RN, Pfaller MA, Cormican MG. 'Infectious Diseases (Bacterial and Fungal): Principles and practice of antimicrobial therapy'. In: Averys Drug Treatment , . [Details]

Cormican M, Glennon M, NiRiain U, Flynn J. 'Multiplex PCR for identification of mycobacterial isolates'. J. Clin. Path, 48 :203-205. [Details]

Cormican MG 'PCR in the detection and typing of mycobacterial infection. In: PCR Applications in Pathology'. Oxford University Press, . [Details]

NiChulain M, Morris D, Cormican M. 'Enterobacteral repetitive intergenic consensus-polymerase chain reaction for typing of uropathogenic Escherichia coli is not what it seems'. Clin. Infect. Dis, 42 (12):1805-1806. [Details]

Cormican MG, Erwin MS, Jones RN. 'Multi-Center Validation of Proposed Disk Diffusion Susceptibility Testing Interpretive Criteria for Lomefloxacin Using More than 1,500 Clinical Isolates'. Diagn. Microbiol. Infect. Dis. Sutton, LD, 24 :169-172. [Details]

Cormican MG, Gilmartin JJ. 'The medical management of respiratory tract infection in the elderly. (Review)'. Irish Medical Journal, 87 :2-3. [Details]

Cormican MG, Glennon M, Ni Riain U, Smith T, Flynn J, Gannon F. 'Evaluation of a PCR assay for detection of Mycobacterium tuberculosis in clinical specimens'. Diagn. Microbiol. Infect. Dis, 22 :357-360. [Details]

NiRiain U, Cormican M, Flynn J, Glennon M, Smith T. 'PCR based fingerprinting of Enterobacter cloacae'. J. Hosp. Inf, 27 :237-240. [Details]

Glennon M, Smith T, Cormican M, Noone D, Barry T, Maher M, Dawson M, Gilmartin JJ, Gannon F. 'The ribosomal inter-genic spacer region: A target for the PCR based diagnosis of tuberculosis'. Tubercle Lung Dis, 75 :353-360. [Details]

Cormican MG, Barry T, Gannon F, Flynn J. 'Clinical usefulness of detecting growth of Mycobacterium tuberculosis in positive Bactec phials using PCR'. J.Clin.Pathol, 47 :190-191. [Details]

Cormican M, Jones RN. 'Cross resistance analysis for clinafloxacin compared with ciprofloxacin, fleroxacin, ofloxacin, and sparfloxacin using a predictor panel of ciprofloxacin-resistant bacteria. J'. Antimicrob. Chemother, 36 :431-434. [Details]

     

Abstract

Cormican, M,Bowker, K,Howe, R,Smyth, E,Jones, R,Biedenbach, D (2008) Dalbavancin Activity Tested Against a Contemporary Collection of Gram-positive Bacteria from Hospitals in the UK and Ireland: Results from DECIDE Program. Abstract [DOI] [Details]

                   

Other Item

CORMICAN, M et al. (1998) Antibiotic resistance amongst Salmonella enterica species isolated in the Republic of Ireland. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY. Other Item [Details]

CORMICAN, M et al. (2000) The DDT question. LANCET. Other Item [Details]

CORMICAN, M et al. (2001) Antimicrobial resistance in Escherichia coli isolates from turkeys and hens in Ireland. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY. Other Item [Details]